Summary & Overview
CPT 94010: Spirometry for Lung Function Assessment
CPT code 94010 is a widely utilized billing code for spirometry, a key diagnostic procedure in pulmonology that measures lung function through vital capacity and expiratory flow rates. This code is central to the evaluation and management of respiratory diseases, including chronic obstructive pulmonary disease, asthma, and emphysema. Nationally, spirometry is performed in outpatient office settings and is covered by major payers such as Aetna, Blue Cross Blue Shield, Cigna Health, Medicare, and UnitedHealthcare.
This publication provides a comprehensive overview of CPT code 94010, including payer coverage, clinical context, and related billing codes. Readers will gain insights into typical use cases, associated diagnoses, and relevant modifiers. The article also highlights related CPT codes for advanced pulmonary function testing and inhalation treatments, offering a broader perspective on respiratory care billing. Policy updates and benchmarks are discussed to inform stakeholders about current trends and requirements in medical billing for spirometry. The summary is designed for healthcare professionals, billing specialists, and policy analysts seeking clarity on the national landscape for spirometry services.
CPT Code Overview
CPT code 94010 represents spirometry, a pulmonary function test that measures total and timed vital capacity and expiratory flow rates, with or without maximal voluntary ventilation. This procedure is essential in the assessment and management of respiratory conditions, providing objective data on lung function. The service is typically performed in an office setting (Place of Service 11) and falls under the pulmonology specialty. Spirometry is a foundational diagnostic tool used by clinicians to evaluate symptoms such as shortness of breath and to monitor chronic lung diseases.
Clinical & Coding Specifications
Clinical Context
A patient presents to a pulmonology office with symptoms such as shortness of breath, chronic cough, or wheezing. The physician suspects a respiratory condition like chronic obstructive pulmonary disease (COPD), asthma, or emphysema. To assess lung function, the provider orders spirometry (94010). The test is performed in the office setting (POS 11), where the patient breathes into a spirometer. The device records total and timed vital capacity and expiratory flow rates, providing graphic data for interpretation. The results help guide diagnosis and management of pulmonary disorders.
Coding Specifications
-
Modifiers:
26: Professional Component – Used when only the physician's interpretation and report are billed, not the technical performance.TC: Technical Component – Used when only the technical performance (equipment and staff) is billed, not the physician's interpretation.
-
Provider Taxonomies:
| Taxonomy Code | Specialty Name |
|---|---|
207RP1001X | Pulmonary Disease Physician |
207RC0200X | Critical Care Medicine Physician |
207RI0008X | Interventional Pulmonology Physician |
These taxonomies represent providers specializing in pulmonary diseases, critical care, and interventional pulmonology.
Related Diagnoses
-
J44.9: Chronic obstructive pulmonary disease, unspecified- Relevant for patients with suspected or known COPD, where spirometry is essential for diagnosis and monitoring.
-
J45.909: Unspecified asthma, uncomplicated- Used for patients with asthma symptoms; spirometry helps assess airway obstruction and response to therapy.
-
R06.02: Shortness of breath- Applied when evaluating unexplained dyspnea; spirometry assists in identifying underlying pulmonary causes.
-
J43.9: Emphysema, unspecified- For patients with emphysema, spirometry quantifies airflow limitation and guides treatment.
-
J98.4: Other disorders of lung- Used for less common pulmonary conditions where spirometry aids in functional assessment.
Related CPT Codes
-
94060: Bronchodilation responsiveness, spirometry as in94010, pre- and post-bronchodilator administration- Used when assessing lung function before and after bronchodilator medication to evaluate airway responsiveness. Commonly performed alongside or as an extension of
94010.
- Used when assessing lung function before and after bronchodilator medication to evaluate airway responsiveness. Commonly performed alongside or as an extension of
-
94640: Pressurized or non-pressurized inhalation treatment for acute airway obstruction or for sputum induction for diagnostic purposes- Used for therapeutic inhalation treatments or sputum induction, often in conjunction with spirometry for patients with acute symptoms.
-
94726: Plethysmography for determination of lung volumes and, when performed, airway resistance- Provides additional lung volume measurements and airway resistance data, supplementing spirometry results.
-
94727: Gas dilution or washout for determination of lung volumes and, when performed, distribution of ventilation and closing volumes- Used for detailed assessment of lung volumes and ventilation distribution, often as an alternative or complement to spirometry.
These codes may be used together in comprehensive pulmonary function testing or as alternatives depending on clinical needs.
National Reimbursement Benchmarks
National mean rates for CPT code 94010 show that commercial payers (BUCA average) reimburse at $30.60, which is significantly higher than Medicare's mean rate of $20.60. Among individual commercial payers, UnitedHealth Group has the highest mean rate at $36.56, while Blue Cross Blue Shield is at $28.35.
Rate dispersion, measured by the difference between the 75th and 25th percentiles, varies across payers. Medicare has the tightest range ($20.00), while UnitedHealth Group and Cigna exhibit the widest dispersions ($18.33 and $17.13, respectively), indicating greater variability in commercial reimbursement rates. Aetna and Blue Cross Blue Shield have moderate ranges ($12.34 and $11.72).
The table and chart below present the full breakdown of national benchmarks for CPT code 94010 by payer, including mean rates and percentile values.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.